For research teamsHelp me find a study
Back to all studies
TerminatedNCT01939548

Two Dose Levels Of Pf-02545920 Compared To Placebo for schizophrenia

This study was terminated in the United States. It is testing Two Dose Levels Of Pf-02545920 Compared To Placebo for schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Two Dose Levels Of Pf-02545920 Compared may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Two Dose Levels Of Pf-02545920 Compared, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateOctober 2013
Recruitment status
Terminated
Enrollment listed in the registry
240
Sponsor
Pfizer
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01939548
Official title
A 12-week , Randomized, Phase 2, Double-blind, Parallel-group Study Of Two Dose Levels Of Pf-02545920 Compared To Placebo In The Adjunctive Treatment Of Outpatients With Sub-optimally Controlled Symptoms Of Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01939548. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 44 sites
  • Birmingham Psychiatry Pharmaceutical Studies, Inc.
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Woodland International Research Group, INC
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development, Inc.
    Cerritos, California
    Site status: Not listed — confirm with the team
  • ProScience Research Group
    Culver City, California
    Site status: Not listed — confirm with the team
  • Synergy Clinical Research of Escondido
    Escondido, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, Inc.
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Pacific Research Partners
    Oakland, California
    Site status: Not listed — confirm with the team
  • Excell Research, Inc.
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Research Center of Orange County
    Orange, California
    Site status: Not listed — confirm with the team
  • CiTrials
    Riverside, California
    Site status: Not listed — confirm with the team
  • CNRI-San Diego, LLC
    San Diego, California
    Site status: Not listed — confirm with the team
  • Sharp Mesa Vista Hospital
    San Diego, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, Inc.
    Torrance, California
    Site status: Not listed — confirm with the team
  • Bliss Basement Pharmacy
    Hartford, Connecticut
    Site status: Not listed — confirm with the team
  • Institute of Living
    Hartford, Connecticut
    Site status: Not listed — confirm with the team
  • Yale University
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center, LLC
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Florida Clinical research Center, LLC
    Brandenton, Florida
    Site status: Not listed — confirm with the team
  • Innovative Clinical Research, Inc.
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Medical Research Group of Central Florida
    Sanford, Florida
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development, Inc.
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Alexian Brothers Center for Psychiatric Research
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Chinmay K. Patel, DO
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Behavioral Health Care Associates
    Schaumburg, Illinois
    Site status: Not listed — confirm with the team
  • Lake Charles Clinical Trials
    Lake Charles, Louisiana
    Site status: Not listed — confirm with the team
  • Louisiana Clinical Research
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • CBH Health, LLC
    Rockville, Maryland
    Site status: Not listed — confirm with the team
  • Psychiatric Care & Research Center
    O'Fallon, Missouri
    Site status: Not listed — confirm with the team
  • St. Louis Clinical Trials/The Summit@Creve Coeur
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Altea Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development
    Jamaica, New York
    Site status: Not listed — confirm with the team
  • Manhattan Psychiatric Center's 125th St. Clinic
    New York, New York
    Site status: Not listed — confirm with the team
  • Manhattan Psychiatric Center
    Ward's Island, New York
    Site status: Not listed — confirm with the team
  • Midwest Clinical Research Center, LLC
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Research Strategies of Memphis, LLC
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • FutureSearch Trials
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Community Clinical Research, Inc
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Futuresearch Trials of Dallas
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research LLC
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • InSite Clinical Research
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Psychiatric and Behaviorial Solutions
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
  • Lifetree Clinical Research
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving PF-02545920, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Pfizer, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.